Adams Wealth Management Cytosorbents Corp Transaction History
Adams Wealth Management
- $474 Million
- Q2 2025
Shares
2 transactions
Others Institutions Holding CTSO
# of Institutions
52Shares Held
16.7MCall Options Held
28.9KPut Options Held
0-
Avenir Corp Washington, DC5.06MShares$4.86 Million0.7% of portfolio
-
Skylands Capital, LLC2.62MShares$2.51 Million0.55% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.12MShares$2.04 Million0.0% of portfolio
-
Neuberger Berman Group LLC New York, NY1.59MShares$1.53 Million0.0% of portfolio
-
Cm Management, LLC1.25MShares$1.2 Million1.64% of portfolio
About Cytosorbents Corp
- Ticker CTSO
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 43,577,400
- Market Cap $41.8M
- Description
- Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...